RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
Fluofarma
High Content Screening Services More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Bone Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 109 pages - $1,000
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
Cancer Targeted Therapies and Immunotherapies Market Forecast
Aug 2010 - $15,200
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
Apr 2011 - 137 pages - $3,500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Oncology del
Bone cancer del
Geographic location
Europe del
France del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service
Therapeutic target
Chondrosarcoma
Ewings Sarcoma
Osteosarcoma
Spindle sarcoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us